Biosensor Support Grant for CGT projects by Jobst Technologies GmbH
In Cell and Gene Therapy (CGT) development and manufacturing excessive needs are placed on repeatability, safety and quality, as well as on process stability. During production crucial insights into the cells condition are gained by monitoring metabolic parameters including Glucose, Lactate and others. Monitoring such parameters is typically done by analyzing samples in large, expensive and complex analyzing instruments that are not available to every researcher and smaller scale company.
Unlike many other bio-pharma therapy products, CGT is depending on reliable processing of small, often patient-derived sample volumes, for which closed-loop metabolic monitoring and control contribute to process success and scalability. The biosensors by Jobst Technologies offer robust and high performing enzymatic based sensor components that enable continuous monitoring as well as automated measurement of small sample volumes. To support the CGT community and advance innovation, we are providing selected projects with our products and expertise to achieve such functionality.
The projects selected for a Biosensor Support Grant for CGT will receive the needed amount of B.LV5 continuous electrochemical biosensors for the measurement of Glucose, Lactate, Glutamine and Glutamate in a flow-through sensor package. This also includes our SIX Read-Out transmitter as well as a ready-to-use software and an open communication protocol. During the project we will be available to assist with sensor integration, give application support, and can further support your automation system with our CPP1 micropumps including the utilization of pre-sterilized microdialysis probes.
We are looking forward to get in contact with you and to review your proposals!
If you are interested, please visit the detailed information at https://www.jobst-technologies.com/biosensor-cgt-support-grant/